Scarica l'app Stockscreener
7.67
11.53%
-1.00
Dopo l'orario di chiusura:
7.83
0.16
+2.09%
Sagimet Biosciences Inc Borsa (SGMT) Ultime notizie
Sagimet Biosciences: Promising Advancements in FASN Inhibitor Platform and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Promising Potential of Sagimet Biosciences’ FASN Inhibitors Drives Buy Rating - TipRanks
Sagimet Biosciences Reports Progress in Acne and MASH Trials - TipRanks
Sagimet Biosciences Reports Q2 Results and Clinical Progress - MSN
Sagimet Biosciences enters $75 million at-the-market sales agreement with Leerink Partners - Investing.com
Sagimet Biosciences Enters New Sales Agreement with Leerink - TipRanks
Sagimet Biosciences, Inc. Class A: Promising Combination Therapy for MASH Drives Buy Rating - TipRanks
Sagimet Biosciences Tops Q2 EPS Forecast - AOL.com
Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Sagimet Biosciences Q2 GAAP EPS Beats by $0.21, Cash Holdings at $135.5M - AInvest
Sagimet Biosciences: Navigating the High-Risk Biopharma Landscape with Operational Gains and Earnings Resilience - AInvest
Sagimet Biosciences Inc Q2 Loss Increases, But Beats Estimates - Nasdaq
Sagimet Reports Q1 Earnings, Advances Denifanstat and TVB-3567 Trials - AInvest
Sagimet Biosciences Inc. SEC 10-Q Report - TradingView
Sagimet Biosciences Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
Wedbush Initiates Sagimet Biosciences at Outperform With $28 Price Target - MarketScreener
Wedbush initiates coverage on Sagimet Biosciences with Outperform rating and $28 PT. - AInvest
Wedbush initiates coverage on Sagimet Biosciences stock with Outperform rating - Investing.com Australia
Can Sagimet Biosciences Inc. Escape Recent Bear ChannelDay Trading Signals With High Precision Reviewed - beatles.ru
Sagimet Biosciences SGMT Q2 2025 Earnings Preview Upside Potential Driven by Strategic Innovations - AInvest
Is This a Bottoming Phase for Sagimet Biosciences Inc.Capital Protection Trading Strategies Gain Interest - beatles.ru
Can volume confirm reversal in Sagimet Biosciences Inc.Chart Driven Entry Timing for Swing Trades - Newser
Sagimet Biosciences Inc. Matches Institutional Buying FilterWeekly Chart Analysis With Entry Advice Provided - beatles.ru
How to recover losses in Sagimet Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
How to build a dashboard for Sagimet Biosciences Inc. stockShort-Term Upside Breakout Forecast System - Newser
How sentiment analysis helps forecast Sagimet Biosciences Inc.Market Opportunity Tracker for Swing Traders - Newser
Can Sagimet Biosciences Inc. recover in the next quarterFree Long Hold Safe Return Strategy - Newser
Sagimet Biosciences assumed with a Buy at H.C. Wainwright - TipRanks
Promising Prospects for Sagimet Biosciences: Buy Rating Backed by Innovative FASN Inhibitor Platform and Clinical Advancements - TipRanks
HC Wainwright maintains Buy rating for Sagimet Biosciences with $29 PT. - AInvest
What makes Sagimet Biosciences Inc. stock price move sharplyPre-Market Stock Movement Summary and Review - Newser
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Clinical-Stage Biotech Sagimet to Share Latest Therapeutic Developments at Major Growth Conference - Stock Titan
Sagimet Biosciences Inc. Testing Reversal Zone on Weekly ChartAlpha Focused Technical Trade Signals Gain Attention - beatles.ru
Is Sagimet Biosciences Inc. a good long term investmentInvest confidently with real-time updates - Jammu Links News
Risk adjusted return profile for Sagimet Biosciences Inc. analyzedMomentum Prediction Based on AI Backtesting - Newser
Is Sagimet Biosciences Inc. stock overvalued or undervaluedMaximize your returns with expert insights - Jammu Links News
What drives Sagimet Biosciences Inc. stock priceCapitalize on momentum-driven investment opportunities - Jammu Links News
Is it the right time to buy Sagimet Biosciences Inc. stockUnstoppable trading performance - Jammu Links News
Should I hold or sell Sagimet Biosciences Inc. stock in 2025Build wealth with high-performing stocks - Jammu Links News
How volatile is Sagimet Biosciences Inc. stock compared to the marketBuild a winning investment strategy - Jammu Links News
How does Sagimet Biosciences Inc. compare to its industry peersBuild wealth faster with consistent investment plans - Jammu Links News
How many analysts rate Sagimet Biosciences Inc. as a “Buy”Build a winning portfolio with smart picks - Jammu Links News
What catalysts could drive Sagimet Biosciences Inc. stock higher in 2025Explosive trading growth - Jammu Links News
What are the technical indicators suggesting about Sagimet Biosciences Inc.Unlock exclusive trading strategies for gains - Jammu Links News
Wyckoff Accumulation Phase Possible in Sagimet Biosciences Inc.Entry Alert Based on Volume Spikes Detected - metal.it
What are the latest earnings results for Sagimet Biosciences Inc.Swing Trade Updates To Watch Now - Jammu Links News
Can Sagimet Biosciences Inc. hit a new high this monthTrade Setups With Clear Risk Limits Highlighted - metal.it
Why Sagimet Biosciences Inc. stock attracts strong analyst attentionEntry Alert With Low Drawdown Strategy Noted - beatles.ru
Sagimet Biosciences Inc. Stock Performance After Earnings: Historical InsightsWeekly Portfolio Update with ROI Focus - Newser
How high can Sagimet Biosciences Inc. stock price go in 2025Daily Stock Forecast Powered by AI Tools - Newser
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):